SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022333
Filing Date
2022-11-07
Accepted
2022-11-07 08:00:59
Documents
99
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clnn-20220930.htm   iXBRL 10-Q 4489166
2 EX-31.1 clnn-ex31_1.htm EX-31.1 17591
3 EX-31.2 clnn-ex31_2.htm EX-31.2 17567
4 EX-32.1 clnn-ex32_1.htm EX-32.1 9664
5 EX-32.2 clnn-ex32_2.htm EX-32.2 9627
6 GRAPHIC img180857224_0.jpg GRAPHIC 508794
  Complete submission text file 0000950170-22-022333.txt   18248967

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clnn-20220930_def.xml EX-101.DEF 325175
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clnn-20220930_lab.xml EX-101.LAB 740240
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clnn-20220930_cal.xml EX-101.CAL 83378
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clnn-20220930.xsd EX-101.SCH 118478
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clnn-20220930_pre.xml EX-101.PRE 542833
93 EXTRACTED XBRL INSTANCE DOCUMENT clnn-20220930_htm.xml XML 4044829
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39834 | Film No.: 221363782
SIC: 2834 Pharmaceutical Preparations